ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,626.02
      0.54%
      US Tech 100
      18,986.40
      0.30%
      Dow Jones
      41,393.78
      0.72%
      Brent Oil
      71.825
      0.00%
      Bitcoin
      59,772.39
      -1.33%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Dominari Holdings Inc (DOMH) Quote

      Dominari Holdings Inc

      Dominari Holdings Inc (DOMH)

      NASDAQ
      1.875
      -0.045
      (-2.34%)
      Closed September 14 4:00PM
      Delayed by 15 minutes
      1.8701
      -0.0049
      (-0.26%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.875
      Bid
      1.83
      Ask
      2.02
      Volume
      3,463
      1.85 Day's Range 1.91
      1.47 52 Week Range 4.45
      Market Cap
      11.768M
      Previous Close
      1.92
      Open
      1.85
      Last Trade
      26
      @
      1.87
      Last Trade Time
      Financial Volume
      $ 6,453
      VWAP
      1.8634
      Average Volume (3m)
      10,121
      Shares Outstanding
      6,276,138
      Dividend Yield
      -
      PE Ratio
      -0.45
      Earnings Per Share (EPS)
      -3.65
      Revenue
      2.04M
      Net Profit
      -22.88M

      About Dominari Holdings Inc

      Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including t... Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Show more

      Sector
      Security Brokers & Dealers
      Industry
      Security Brokers & Dealers
      Website
      www.dominariholdings.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Dominari Holdings Inc is listed in the Security Brokers & Dealers sector of the NASDAQ with ticker DOMH. The last closing price for Dominari was $1.92. Over the last year, Dominari shares have traded in a share price range of $ 1.47 to $ 4.45.

      Dominari currently has 6,276,138 shares outstanding. The market capitalization of Dominari is $12.05 million. Dominari has a price to earnings ratio (PE ratio) of -0.45.

      Ask ADVFN Intelligence (AI)

      DOMH Latest News

      More News

      Form PRE 14A - Other preliminary proxy statements

      23 hours ago
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 29 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 14 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      July 11 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 18 2024
      Edgar (US Regulatory)

      Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

      June 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 13 2024
      Edgar (US Regulatory)

      Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

      June 13 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.2313.98176291791.6452.07371.581371.7699351CS
      4-0.105-5.303030303031.982.131.4780101.82154426CS
      12-0.255-11.97183098592.133.21.47101212.25933076CS
      26-0.795-29.77528089892.673.21.47108692.2479966CS
      52-1.335-41.58878504673.214.451.47143332.89261452CS
      156-1.335-41.58878504673.214.451.47143332.89261452CS
      2600002.0737000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NOVVUNova Vision Acquisition Corporation
      $ 41.00
      (207.35%)
      		17.4k
      NOVVNova Vision Acquisition Corporation
      $ 37.0001
      (200.08%)
      		205.22k
      SMXSMX Security Matters Public Company
      $ 5.85
      (138.78%)
      		50.1M
      OMICSingular Genomics Systems Inc
      $ 12.38
      (119.12%)
      		2.87M
      TILInstill Bio Inc
      $ 84.75
      (82.41%)
      		3.91M
      GSIWGarden Stage Ltd
      $ 2.9693
      (-75.66%)
      		4.24M
      UPCUniverse Pharmaceuticals Inc
      $ 0.55
      (-67.07%)
      		30.45M
      VMARVision Marine Technologies Inc
      $ 0.77
      (-48.67%)
      		34.54M
      PRLDPrelude Therapeutics Inc
      $ 2.775
      (-42.55%)
      		2.49M
      CNEYCN Energy Group Inc
      $ 0.4335
      (-37.17%)
      		5.06M
      NVDANVIDIA Corporation
      $ 119.10
      (-0.03%)
      		238.43M
      XXII22nd Century Group Inc
      $ 0.3447
      (28.00%)
      		183.73M
      IMRXImmuneering Corporation
      $ 2.02
      (41.26%)
      		136.36M
      SQQQProShares UltraPro Short QQQ
      $ 8.17
      (-1.33%)
      		127.78M
      MULNMullen Automotive Inc
      $ 0.1328
      (-20.48%)
      		120.81M

      Discussion

      View Full Feed
      hunchboy hunchboy 54 seconds ago
      50 million , 100, 200 how many.
      DROR
      justsayin justsayin 1 minute ago
      Glad I picked up a few more 5’s. Next week will be interesting.
      AAPJ
      barnyarddog barnyarddog 1 minute ago
      Shell Recharge Solutions’ Post

      4mo
      https://www.linkedin.com/posts/shell-recharge-solutions_from-27th-may-you-can-stay-updated-on-shell-activity-7196884975479062528-jGbH


      Shell Recharge Solutions
      56,262 followers
      2mo
      Shell Recharge So
      DCFCQ
      DewDiligence DewDiligence 1 minute ago
      Re: Tender offer commencement

      RVNC’s 8-K filed 8/28/24 says, “…to September 13, 2024 or such other date as may be agreed to between the Company and Parent.” Emphasis added.

      So, the tender offer has apparently been delayed again. We should find out more by Monday.
      RVNC
      ipiros ipiros 2 minutes ago
      https://x.com/igex_official/status/1782394926220615912?s=46&t=1mtQtgXmx35-BlWutjUYiQ


      Maybe this?
      FMNJ
      satter satter 2 minutes ago
      Rumors are flying on this. Please note I said Rumors only.
      richme richme 5 minutes ago
      Great information. Thanks!!!
      BNCM
      1vman 1vman 5 minutes ago
      *****🅰️🅰️🅰️ Short story long DBMM is a failing company for 20 years thats going down hill fast ! -- Wh👀ps !

      ENOUGH SAID
      DBMM
      PutzMueler PutzMueler 5 minutes ago
      Not to mention the FAA has no ooops factor. They have to make certain what’s going up is going to stay up unless something out of Space X’s control brings it down.

      Canadian and USA miners like NioCorp are under a different umbrella.

      The FUA
      Federal Underground A
      NB
      TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
      Quiet board
      KODK
      TRUSTUNITS1000000 TRUSTUNITS1000000 7 minutes ago
      Great share structure
      KODK
      TRUSTUNITS1000000 TRUSTUNITS1000000 7 minutes ago
      Price predictions
      KODK
      DewDiligence DewDiligence 7 minutes ago
      PFE phase-2 cachexia trial meets primary endpoint—data presented at ESMO and published in NEJM:

      https://www.businesswire.com/news/home/20240913347614/en Pfizer…today announced its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (G
      PFE
      mick mick 7 minutes ago
      https://swingtradebot.com/industries/154-shell-companies#sub_news
      mick mick 7 minutes ago
      https://swingtradebot.com/industries/154-shell-companies#sub_news
      WesCrowe WesCrowe 8 minutes ago
      Trying to do some digging on Silica Scientific. Looks like a fairly new Corp reporting active and profits. Since 2022. Listed at Ripplinger address in Millville, Utah. Minerals and Quarry services.
      BRNE
      Walter4 Walter4 8 minutes ago
      https://youtu.be/9V3h3y-SwL0?si=TBeP3QYfDqoxPDMK
      SONG
      mick mick 8 minutes ago
      https://swingtradebot.com/industries/154-shell-companies#sub_news
      TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
      Interesting company
      KODK
      doc2016 doc2016 8 minutes ago
      lawyers do what lawyers do. judges allow what they allow.
      we don't know all the reasons or answers.
      show us the money , and all is forgiven.
      however, there is a limit to all of our patience.
      arbitration thought should already be done , just plug in the numbers into th
      richme richme 8 minutes ago
      https://www.wsj.com/market-data/quotes/BNCM/research-ratings
      AT CLOSE 3:19 PM EDT 09/13/24 $0.07 USD -0.001 -1.41%
      Volume 431,477 65 Day Avg Vol 436,196 1
      Day Range 0.0601 - 0.08 52 Week Range 0.0014 - 0.08
      Interesting data from the WSJ.
      Thanks.
      (10/26/23 -
      BNCM
      DewDiligence DewDiligence 8 minutes ago
      PFE phase-2 cachexia trial meets primary endpoint—data presented at ESMO and published in NEJM:

      https://www.businesswire.com/news/home/20240913347614/en Pfizer…today announced its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (G
      PFE
      TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
      Great share structure
      DCMDF
      DewDiligence DewDiligence 8 minutes ago
      BNTX's data must look very good indeed for the EV to increase by ~40% in one day.
      BNTX
      Testpilot Testpilot 9 minutes ago
      https://stocktwits.com/16driver/message/586077809
      CRTG

      Your Recent History

      NASDAQ
      DOMH
      Dominari
      Delayed Upgrade Clock